Go Pro
LON:EKF

EKF Diagnostics (EKF) Share Price, News & Analysis

EKF Diagnostics logo
GBX 25.60 +0.20 (+0.79%)
As of 12:00 PM Eastern

About EKF Diagnostics Stock (LON:EKF)

Advanced

Key Stats

Today's Range
25.01
25.60
50-Day Range
24.60
26.30
52-Week Range
22
31.70
Volume
77,734 shs
Average Volume
316,154 shs
Market Capitalization
£109.61 million
P/E Ratio
54.47
Dividend Yield
4.65%
Price Target
GBX 35
Consensus Rating
Buy

Company Overview

EKF is an AIM-listed global diagnostics business focussed on: ● Point-of-Care analysers in the key areas of Hematology and Diabetes ● Life Sciences services provide specialist manufacture of enzymes and custom products for use in diagnostic, food and industrial applications. EKF has headquarters in Penarth (near Cardiff) and operates five manufacturing sites across the US and Germany, selling into over 120 countries world-wide.

Receive EKF Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for EKF Diagnostics and its competitors with MarketBeat's FREE daily newsletter.

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

EKF Stock News Headlines

EKF Diagnostics (EKF) Stock Forecast & Price Target
The $15 Gold Fund That Pays Up to $1,152/Month
Gold is hitting record highs, but most investors are leaving income on the table. A $15 fund is quietly paying out up to $1,152 a month to regular investors - no mining stocks, no options, no physical metal required. Chief Income Strategist Tim Plaehn calls it a breakthrough strategy that transforms gold's rally into reliable monthly payouts. The next distribution is just days away.tc pixel
EKF Diagnostics Holdings plc (EKDHF)
See More Headlines

EKF Stock Analysis - Frequently Asked Questions

EKF Diagnostics' stock was trading at GBX 26.10 at the beginning of 2026. Since then, EKF stock has decreased by 1.9% and is now trading at GBX 25.60.

EKF Diagnostics Holdings plc (LON:EKF) released its quarterly earnings results on Tuesday, March, 24th. The company reported $0.47 EPS for the quarter. EKF Diagnostics had a trailing twelve-month return on equity of 3.01% and a net margin of 4.12%.

Shares of EKF stock and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.

Based on aggregate information from My MarketBeat watchlists, some other companies that EKF Diagnostics investors own include ERBA Diagnostics (ERBA), boohoo group (BOO), Lloyds Banking Group (LLOY), 888 (888), Abcam (ABC), ASOS (ASC) and Babcock International Group (BAB).

Company Calendar

Last Earnings
3/24/2026
Today
9/10/2026

Industry, Sector and Symbol

Stock Exchange
LON
Industry
Healthcare Equipment & Supplies
Sub-Industry
N/A
Current Symbol
LON:EKF
CIK
N/A
Fax
N/A
Employees
356
Year Founded
N/A

Price Target and Rating

High Price Target
GBX 35
Low Price Target
GBX 35
Potential Upside/Downside
+36.7%
Consensus Rating
Buy
Rating Score (0-4)
3.00
Research Coverage
1 Analysts

Profitability

EPS (Trailing Twelve Months)
GBX 0.47
Trailing P/E Ratio
54.47
Forward P/E Ratio
11.14
P/E Growth
N/A
Net Income
£4.68 million
Net Margins
4.12%
Pretax Margin
N/A
Return on Equity
3.01%
Return on Assets
5.27%

Debt

Debt-to-Equity Ratio
2.01
Current Ratio
4.16
Quick Ratio
1.77

Sales & Book Value

Annual Sales
£51.56 million
Price / Sales
2.13
Cash Flow
GBX 2.41 per share
Price / Cash Flow
10.64
Book Value
GBX 15.41 per share
Price / Book
1.66

Miscellaneous

Outstanding Shares
428,153,000
Free Float
N/A
Market Cap
£109.61 million
Optionable
Not Optionable
Beta
0.50
7 Stocks That Will Be Magnificent in 2026 Cover

Discover the next wave of investment opportunities with our report, 7 Stocks That Will Be Magnificent in 2026. Explore companies poised to replicate the growth, innovation, and value creation of the tech giants dominating today's markets.

Get This Free Report

This page (LON:EKF) was last updated on 9/10/2026 by MarketBeat.com Staff.
From Our Partners